Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline leads a $21M round for PhII kidney drug developer Thrasos
GlaxoSmithKline leads a $21M round for PhII kidney drug developer Thrasos
GlaxoSmithKline leads a $21M round for PhII kidney drug developer Thrasos
Submitted by
admin
on March 31, 2015 - 12:42pm
Source:
Fierce Biotech
News Tags:
GSK
Thrasos Therapeutics
acute kidney injury
chronic kidney disease
Headline:
GlaxoSmithKline leads a $21M round for PhII kidney drug developer Thrasos
Do Not Allow Advertisers to Use My Personal information
